Genetic Counseling and Long-Term Surveillance Using a Multidisciplinary Approach in von Hippel–Lindau Disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: von Hippel–Lindau (VHL) disease is an autosomal dominant disorder caused by variants of the VHL tumor suppressor gene (VHL). Early detection and treatment are essential to prevent morbidity and mortality. We evaluated the effectiveness of surveillance strategies and the utility of a VHL clinic with a multidisciplinary team for the first time in Korea. Methods: The VHL clinic was organized at the Samsung Medical Center in 2011 and consisted of a multidisciplinary team, including an endocrinologist, urologist, general surgeon, neurosurgeon, ophthalmologist, otolaryngologist, and radiologist. Biochemical and imaging surveillance and personalized genetic counseling were conducted at the VHL clinic and patients were referred to the necessary departments upon detection of disease manifestation. We divided the patients in three groups (I–III) based on their compliance to VHL clinic attendance. Results: Between 2011 and 2018, 50 VHL patients were identified by VHL molecular analysis and referred to the VHL clinic. Most patients regularly participated in imaging of the central nervous system (43/50, 86.0%) and of the abdomen (46/50, 92.0%). However, there were differences in compliance to determination of the catecholamine level, audiometry, and ophthalmic examination among the three groups. Conclusions: We present the results of using a multidisciplinary team approach and showed that the VHL clinic strategy is useful for the comprehensive surveillance and management of VHL disease. We hope that VHL clinics will be widely set up in hospitals to improve prognosis in patients with VHL.
Abstract
Background: von Hippel–Lindau (VHL) disease is an autosomal dominant disorder caused by variants of the VHL tumor suppressor gene (VHL). Early detection and treatment are essential to prevent morbidity and mortality. We evaluated the effectiveness of surveillance strategies and the utility of a VHL clinic with a multidisciplinary team for the first time in Korea. Methods: The VHL clinic was organized at the Samsung Medical Center in 2011 and consisted of a multidisciplinary team, including an endocrinologist, urologist, general surgeon, neurosurgeon, ophthalmologist, otolaryngologist, and radiologist. Biochemical and imaging surveillance and personalized genetic counseling were conducted at the VHL clinic and patients were referred to the necessary departments upon detection of disease manifestation. We divided the patients in three groups (I–III) based on their compliance to VHL clinic attendance. Results: Between 2011 and 2018, 50 VHL patients were identified by VHL molecular analysis and referred to the VHL clinic. Most patients regularly participated in imaging of the central nervous system (43/50, 86.0%) and of the abdomen (46/50, 92.0%). However, there were differences in compliance to determination of the catecholamine level, audiometry, and ophthalmic examination among the three groups. Conclusions: We present the results of using a multidisciplinary team approach and showed that the VHL clinic strategy is useful for the comprehensive surveillance and management of VHL disease. We hope that VHL clinics will be widely set up in hospitals to improve prognosis in patients with VHL.
참고문헌 (23)
- Lonser RR, "von Hippel-Lindau disease", Lancet, 361, pp.2059~2067 (2003)
- Kamura T, "Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase", Science, 284, pp.657~661 (1999)
- Maxwell PH, "The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis", Nature, 399, pp.271~275 (1999)
- Maher ER, "Phenotypic expression in von Hippel-Lindau disease : correlations with germline VHL gene mutations", J Med Genet, 33, pp.328~332 (1996)
- Varshney N, "A Review of Von Hippel-Lindau Syndrome", J Kidney Cancer VHL, 4, pp.20~29 (2017)
- Wilding A, "Life expectancy in hereditary cancer predisposing diseases : an observational study", J Med Genet, 49, pp.264~269 (2012)
- Binderup MLM, "von Hippel-Lindau disease : Diagnosis and factors influencing disease outcome", Dan Med J, 65 (2018)
- Dornbos D 3rd, "Review of the Neurological Implications of von Hippel-Lindau Disease", JAMA Neurol, 75, pp.620~627 (2018)
- Poulsen ML, "Surveillance in von Hippel-Lindau disease(vHL)", Clin Genet, 77, pp.49~59 (2010)
- Metelo AM, "HIF2a inhibitors for the treatment of VHL disease", Oncotarget, 6, pp.23036~23037 (2015)
- Schunemann V, "Personalized Medicine for Nervous System Manifestations of von Hippel-Lindau Disease", Front Surg, 3, pp.39~ (2016)
- Yang C, "Proteostasis modulators prolong missense VHL protein activity and halt tumor progression", Cell Rep, 3, pp.52~59 (2013)
- alliance V, "VHLA Suggested Active Surveillance Guidelines", ~ (2020)
- Binderup ML, "Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark", Eur J Hum Genet, 25, pp.301~307 (2017)
- Maher ER, "von Hippel-Lindau disease : a clinical and scientific review", Eur J Hum Genet, 19, pp.617~623 (2011)
- Nielsen SM, "Von Hippel-Lindau Disease : Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome", J Clin Oncol, 34, pp.2172~2181 (2016)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- 조현정, "Improved Detection of Germline Mutations in Korean VHL Patients by Multiple Ligation-dependent Probe Amplification Analysis", Journal of Korean Medical Science, 24(1), pp.77~83 (2009), 대한의학회
- Hwang S, "Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel-Lindau(VHL)disease", J Hum Genet, 59, pp.488~493 (2014)
- Ahn HS, "Thyroid Cancer Screening in South Korea Increases Detection of Papillary Cancers with No Impact on Other Subtypes or Thyroid Cancer Mortality", Thyroid, 26, pp.1535~1540 (2016)
- Wu P, "Family history of von Hippel-Lindau disease was uncommon in Chinese patients : suggesting the higher frequency of de novo mutations in VHL gene in these patients", J Hum Genet, 57, pp.238~243 (2012)
- Binderup ML, "Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition", Dan Med J, 60, pp.B4763~ (2013)
- Launbjerg K, "von Hippel-Lindau development in children and adolescents", Am J Med Genet A, 173, pp.2381~2394 (2017)